Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Long-term oncological outcomes of patients with paratesticular sarcoma.

Goldberg H, Wong LM, Dickson B, Catton C, Yap SA, Alkasab T, Evans A, van der Kwast T, Jewett MAS, Hamilton RJ.

BJU Int. 2019 Apr 18. doi: 10.1111/bju.14775. [Epub ahead of print]

PMID:
31001920
2.

A new species of Landrevinae (Orthoptera) from the Philippines, with notes on Endodrelanva and Endolandrevus (Orthoptera: Gryllidae; Gryllinae; Landrevini).

Tan MK, Gorochov AV, Baroga-Barbecho JB, Yap SA.

Zootaxa. 2019 Jan 11;4544(2):285-295. doi: 10.11646/zootaxa.4544.2.8.

PMID:
30647270
3.

New taxa and notes on spine-headed katydids (Orthoptera: Conocephalinae: Agraeciini) from the Philippines.

Tan MK, Ingrisch S, Robillard T, Baroga-Barbecho JB, Yap SA.

Zootaxa. 2018 Aug 28;4462(3):331-348. doi: 10.11646/zootaxa.4462.3.2.

PMID:
30314031
4.

Immediate intravesical chemotherapy for low-grade bladder tumors in California: An underutilized practice and its impact on recurrence.

Yap SA, Brunson A, Pugashetti N, M P H RDC, Keegan THM, deVere White R, Wun T.

Urol Oncol. 2018 Nov;36(11):498.e1-498.e7. doi: 10.1016/j.urolonc.2018.08.004. Epub 2018 Sep 17.

PMID:
30236855
5.

Two Cases of Arterioureteral Fistula in the Setting of Previous Radiation Therapy and Indwelling Ureteral Stents: Results of Endovascular Management.

Chandrasekar T, Pugashetti N, Klaassen Z, Goldberg H, Dong P, Yap SA.

Clin Genitourin Cancer. 2018 Oct;16(5):e979-e983. doi: 10.1016/j.clgc.2018.04.003. Epub 2018 Apr 28. No abstract available.

PMID:
29776676
6.

Bacteriophage Infectivity Against Pseudomonas aeruginosa in Saline Conditions.

Scarascia G, Yap SA, Kaksonen AH, Hong PY.

Front Microbiol. 2018 May 2;9:875. doi: 10.3389/fmicb.2018.00875. eCollection 2018.

7.

Sociodemographic disparities in chemotherapy treatment and impact on survival among patients with metastatic bladder cancer.

Klapheke A, Yap SA, Pan K, Cress RD.

Urol Oncol. 2018 Jun;36(6):308.e19-308.e25. doi: 10.1016/j.urolonc.2018.03.008. Epub 2018 Apr 5.

8.

Identification of novel genes in the carotenogenic and oleaginous yeast Rhodotorula toruloides through genome-wide insertional mutagenesis.

Liu Y, Koh CMJ, Yap SA, Du M, Hlaing MM, Ji L.

BMC Microbiol. 2018 Feb 21;18(1):14. doi: 10.1186/s12866-018-1151-6.

9.

A contemporary population-based study of testicular sex cord stromal tumours: Presentation, treatment patterns, and predictors of outcome.

Yuh LM, Lara PN Jr, Wagenaar RM, Evans CP, Dall'era MA, Cress R, Yap SA.

Can Urol Assoc J. 2017 Sep;11(9):E344-E349. doi: 10.5489/cuaj.4402.

10.

Microchamber Cultures of Bladder Cancer: A Platform for Characterizing Drug Responsiveness and Resistance in PDX and Primary Cancer Cells.

Gheibi P, Zeng S, Son KJ, Vu T, Ma AH, Dall'Era MA, Yap SA, de Vere White RW, Pan CX, Revzin A.

Sci Rep. 2017 Sep 25;7(1):12277. doi: 10.1038/s41598-017-12543-9.

11.

Utility of Anterior Zone Biopsy in Men Enrolled in Active Surveillance for Prostate Cancer.

Glass AS, Pugashetti NB, Dall'Era MA, Evans CP, Yap SA.

Clin Genitourin Cancer. 2017 Jul 14. pii: S1558-7673(17)30204-5. doi: 10.1016/j.clgc.2017.07.007. [Epub ahead of print]

PMID:
28789835
12.

Effect of Neoadjuvant Chemotherapy on Renal Function following Radical Cystectomy: Is there a Meaningful Impact?

Chandrasekar T, Pugashetti N, Durbin-Johnson B, Dall'Era MA, Evans CP, deVere White RW, Yap SA.

Bladder Cancer. 2016 Oct 27;2(4):441-448. doi: 10.3233/BLC-160071.

14.

Two new species of Eneopterinae crickets (Orthoptera: Gryllidae) from Luzon, Philippines.

Baroga JB, Yap SA, Robillard T.

Zootaxa. 2016 Jul 19;4139(1):93-105. doi: 10.11646/zootaxa.4139.1.5.

PMID:
27470787
15.

Decreased expression of let-7c is associated with non-response of muscle-invasive bladder cancer patients to neoadjuvant chemotherapy.

Vinall RL, Tepper CG, Ripoll AA, Gandour-Edwards RF, Durbin-Johnson BP, Yap SA, Ghosh PM, deVere White RW.

Genes Cancer. 2016 Mar;7(3-4):86-97. doi: 10.18632/genesandcancer.103.

16.

Evolving patterns of care in the management of stage I non-seminomatous germ cell tumors: data from the California Cancer Registry.

Yap SA, Yuh LM, Evans CP, Dall'Era MA, Wagenaar RM, Cress R, Lara PN Jr.

World J Urol. 2017 Feb;35(2):277-283. doi: 10.1007/s00345-016-1870-y. Epub 2016 Jun 15.

PMID:
27306686
17.

A phase 2 clinical trial of everolimus plus bicalutamide for castration-resistant prostate cancer.

Chow H, Ghosh PM, deVere White R, Evans CP, Dall'Era MA, Yap SA, Li Y, Beckett LA, Lara PN Jr, Pan CX.

Cancer. 2016 Jun 15;122(12):1897-904. doi: 10.1002/cncr.29927. Epub 2016 Mar 28.

18.

Should we worry about positive surgical margins in prostate cancer?

Yap SA.

BJU Int. 2016 Feb;117(2):207-8. doi: 10.1111/bju.13230. No abstract available.

19.

Quantifying patient care: What metrics do we use?

Yap SA.

Can Urol Assoc J. 2015 Mar-Apr;9(3-4):E228-9. doi: 10.5489/cuaj.2875. No abstract available.

20.

Metastatic signet-ring cell carcinoma of the urinary bladder: A novel management approach to a rare tumour.

Pugashetti N, Yap SA, Lara PN Jr, Gandour-Edwards R, Dall'Era MA.

Can Urol Assoc J. 2015 Mar-Apr;9(3-4):E204-7. doi: 10.5489/cuaj.2447.

21.

The role of EGFR family inhibitors in muscle invasive bladder cancer: a review of clinical data and molecular evidence.

Mooso BA, Vinall RL, Mudryj M, Yap SA, deVere White RW, Ghosh PM.

J Urol. 2015 Jan;193(1):19-29. doi: 10.1016/j.juro.2014.07.121. Epub 2014 Aug 23. Review.

22.

Partial nephrectomy for the treatment of renal cell carcinoma (RCC) and the risk of end-stage renal disease (ESRD).

Yap SA, Finelli A, Urbach DR, Tomlinson GA, Alibhai SM.

BJU Int. 2015 Jun;115(6):897-906. doi: 10.1111/bju.12883. Epub 2015 Feb 5.

23.

Long-term outcomes following Medtronic Open Pivot valved conduit.

Naidoo R, Pearse B, Tesar PJ, Yap SA, Barnett AG, Fayers T.

J Heart Valve Dis. 2014 Jan;23(1):105-11.

PMID:
24779336
24.

Ablative efficiency of 532-nm laser vaporization compared to transurethral resection of the prostate: results from a prospective three-dimensional ultrasound volumetry study.

Hermanns T, Gross O, Kranzbühler B, Hefermehl LJ, Poyet C, Müller A, Yap SA, Michel MS, Eberli D, Müntener M, Zimmermann M, Sulser T, Seifert HH.

World J Urol. 2014 Oct;32(5):1267-74. doi: 10.1007/s00345-013-1203-3. Epub 2013 Oct 31.

PMID:
24173627
25.

A population-based study of surgeon characteristics associated with the uptake of contemporary techniques in renal surgery.

Yap SA, Alibhai SM, Margel D, Abouassaly R, Timilshina N, Finelli A.

Can Urol Assoc J. 2013 Sep-Oct;7(9-10):E576-81. doi: 10.5489/cuaj.182.

26.

Treating small renal masses: Costing it out.

Yap SA, Finelli A, Alibhai SM.

Can Urol Assoc J. 2013 Mar-Apr;7(3-4):114-5. doi: 10.5489/cuaj.718. No abstract available.

27.

Renal biopsies for small renal masses. For whom, when and how.

Stakhovsky O, Sanchez-Salas R, Barret E, Yap SA, Finelli A, Rozet F, Galiano M, Lenoir S, Strauss C, Validire P, Cathelineau X.

Arch Esp Urol. 2013 Jan-Feb;66(1):4-15. Review.

PMID:
23406796
28.

Ipsilateral adrenalectomy at the time of radical nephrectomy impacts overall survival.

Yap SA, Alibhai SM, Abouassaly R, Timilshina N, Margel D, Finelli A.

BJU Int. 2013 Mar;111(3 Pt B):E54-8. doi: 10.1111/j.1464-410X.2012.11435.x. Epub 2012 Oct 8.

29.

The emerging role of percutaneous biopsy in diagnosis and management of small renal masses.

Yap SA, Stakhovskyi O, Finelli A.

Curr Opin Urol. 2012 Sep;22(5):360-4. doi: 10.1097/MOU.0b013e3283542bc5. Review.

PMID:
22517034
30.

Predictors of early mortality after radical nephrectomy with renal vein or inferior vena cava thrombectomy - a population-based study.

Yap SA, Horovitz D, Alibhai SM, Abouassaly R, Timilshina N, Finelli A.

BJU Int. 2012 Nov;110(9):1283-8. doi: 10.1111/j.1464-410X.2012.11125.x. Epub 2012 Apr 13.

31.

Impact of multiparametric endorectal coil prostate magnetic resonance imaging on disease reclassification among active surveillance candidates: a prospective cohort study.

Margel D, Yap SA, Lawrentschuk N, Klotz L, Haider M, Hersey K, Finelli A, Zlotta A, Trachtenberg J, Fleshner N.

J Urol. 2012 Apr;187(4):1247-52. doi: 10.1016/j.juro.2011.11.112. Epub 2012 Feb 14.

PMID:
22335871
32.

Do we continue to unnecessarily perform ipsilateral adrenalectomy at the time of radical nephrectomy? A population based study.

Yap SA, Alibhai SM, Abouassaly R, Timilshina N, Finelli A.

J Urol. 2012 Feb;187(2):398-404. doi: 10.1016/j.juro.2011.10.030. Epub 2011 Dec 15.

PMID:
22177155
33.

Small renal mass: what the urologist needs to know for treatment planning and assessment of treatment results.

Stakhovskyi O, Yap SA, Leveridge M, Lawrentschuk N, Jewett MA.

AJR Am J Roentgenol. 2011 Jun;196(6):1267-73. doi: 10.2214/AJR.10.6336. Review. Erratum in: AJR Am J Roentgenol. 2012 May;198(5):1232. Lawrentchuk, Nathan [corrected to Lawrentschuk, Nathan].

PMID:
21606288
34.

Effect of age on transitional cell carcinoma of the upper urinary tract: presentation, treatment, and outcomes.

Yap SA, Schupp CW, Chamie K, Evans CP, Koppie TM.

Urology. 2011 Jul;78(1):87-92. doi: 10.1016/j.urology.2011.03.032. Epub 2011 May 23.

PMID:
21601253
35.
36.

Current perceptions of resident training in laparoscopic nephrectomy.

Yap SA, DeLair SM, Tanaka ST, Kurzrock EA.

Urology. 2009 May;73(5):1067-71. doi: 10.1016/j.urology.2008.08.520.

PMID:
19394507
37.

Incontinent ileovesicostomy: Long-term outcomes and complications.

Hellenthal NJ, Short SS, O'Connor RC, Eandi JA, Yap SA, Stone AR.

Neurourol Urodyn. 2009;28(6):483-6. doi: 10.1002/nau.20695.

PMID:
19274757
38.

Manuscript publication by urology residents and predictive factors.

Hellenthal NJ, Ramírez ML, Yap SA, Kurzrock EA.

J Urol. 2009 Jan;181(1):281-6; discussion 286-7. doi: 10.1016/j.juro.2008.09.022. Epub 2008 Nov 14.

PMID:
19013611
39.
40.

Training residents in hypospadias repair: variations of involvement.

DeLair SM, Tanaka ST, Yap SA, Kurzrock EA.

J Urol. 2008 Mar;179(3):1102-6. doi: 10.1016/j.juro.2007.10.090. Epub 2008 Jan 18.

PMID:
18206935
41.

Novel technique for testicular salvage after combat-related genitourinary injury.

Yap SA, DeLair SM, Ellison LM.

Urology. 2006 Oct;68(4):890.e11-2.

PMID:
17070380

Supplemental Content

Support Center